Discover how different T-cell therapies, including CAR-T and bispecific antibodies, can be used to treat blood cancers. This video series discusses how T-cell treatments work, their different side effect profiles and methods of administration, and their uses across haematology and beyond.
Introduction to CAR-T
Dr Elaine Vickers PhD, discusses what CAR-T is, and how CAR-Ts can be used to treat cancers.
CAR Proteins and their Targets
Dr Elaine Vickers PhD, discusses what CAR proteins are, and how they enable CAR-T cells to recognise and kill cancer.
Differences between CAR-T Products
Dr Elaine Vickers PhD discusses how CAR-T products differ from each other, explaining differences in their targets, signalling domains, T-cell types, and manufacturing processes.
Reasons for resistance, relapse, and side effects with CAR-T
Dr Elaine Vickers PhD discusses why not everyone is cured by CAR T cell therapy and the reasons for its main side effects.
Improving CAR-T cell therapies
Dr Elaine Vickers PhD, discusses some of the challenges of CAR-T cell therapy, and how scientists and doctors are working to overcome these.
Beyond blood cancers: Expanding the uses of CAR T cells
Dr Elaine Vickers PhD discusses how CAR T cell therapy could be used to treat other diseases, like solid tumours and autoimmune conditions.
Introducing T cell engagers
Dr Elaine Vickers PhD discusses what T cell engagers are, associated toxicities and resistance mechanisms, and how scientists are working to improve them.
Comparing CAR-T cells and T cell engagers
Dr Elaine Vickers PhD discusses the differences between CAR T cells and T cell engagers, key similarities and differences.
Only to be shared with relevant UK haematology healthcare professionals.
CPD® Accreditation
To support your continued professional development the resources hosted in the Knowledge Centre have been certified for CPD® accreditation by the CPD® Certification Service.
Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.
GB-75981 | April 2026
